BR112022018287A2 - Compostos moduladores de gpr52 - Google Patents
Compostos moduladores de gpr52Info
- Publication number
- BR112022018287A2 BR112022018287A2 BR112022018287A BR112022018287A BR112022018287A2 BR 112022018287 A2 BR112022018287 A2 BR 112022018287A2 BR 112022018287 A BR112022018287 A BR 112022018287A BR 112022018287 A BR112022018287 A BR 112022018287A BR 112022018287 A2 BR112022018287 A2 BR 112022018287A2
- Authority
- BR
- Brazil
- Prior art keywords
- gpr52
- modulating compounds
- report
- compounds
- modulating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Amplifiers (AREA)
- Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2003668.7A GB202003668D0 (en) | 2020-03-13 | 2020-03-13 | GPR52 Modulator compounds |
| PCT/GB2021/050638 WO2021181122A1 (en) | 2020-03-13 | 2021-03-15 | Gpr52 modulator compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022018287A2 true BR112022018287A2 (pt) | 2022-11-22 |
Family
ID=70453676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022018287A BR112022018287A2 (pt) | 2020-03-13 | 2021-03-15 | Compostos moduladores de gpr52 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20240254101A1 (https=) |
| EP (1) | EP4117784B1 (https=) |
| JP (1) | JP7492597B2 (https=) |
| KR (1) | KR20220152296A (https=) |
| CN (1) | CN115515681B (https=) |
| AU (1) | AU2021235257A1 (https=) |
| BR (1) | BR112022018287A2 (https=) |
| CA (1) | CA3175429A1 (https=) |
| DK (1) | DK4117784T3 (https=) |
| ES (1) | ES2992600T3 (https=) |
| FI (1) | FI4117784T3 (https=) |
| GB (1) | GB202003668D0 (https=) |
| HR (1) | HRP20241375T1 (https=) |
| HU (1) | HUE068758T2 (https=) |
| IL (1) | IL296413B2 (https=) |
| LT (1) | LT4117784T (https=) |
| MX (1) | MX2022011333A (https=) |
| PL (1) | PL4117784T3 (https=) |
| PT (1) | PT4117784T (https=) |
| RS (1) | RS66063B1 (https=) |
| SI (1) | SI4117784T1 (https=) |
| SM (1) | SMT202400402T1 (https=) |
| WO (1) | WO2021181122A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202206413A (zh) | 2020-04-22 | 2022-02-16 | 美商紐羅克里生物科學有限公司 | Gpr52調節劑及其使用方法 |
| EP4330232A1 (en) * | 2021-04-26 | 2024-03-06 | Neurocrine Biosciences, Inc. | Gpr52 modulators and methods of use |
| GB202113186D0 (en) | 2021-09-15 | 2021-10-27 | Heptares Therapeutics Ltd | GPR52 Modulator compounds |
| WO2024091541A1 (en) * | 2022-10-26 | 2024-05-02 | Neurocrine Biosciences, Inc. | Compounds and compositions as gpr52 modulators |
| JP2026508053A (ja) * | 2022-10-26 | 2026-03-10 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | Ｇｐｒ５２モジュレーターとしての化合物および組成物 |
| WO2024091542A1 (en) * | 2022-10-26 | 2024-05-02 | Neurocrine Biosciences, Inc. | Compounds and compositions as gpr52 modulators |
| WO2025252061A1 (zh) * | 2024-06-04 | 2025-12-11 | 海思科医药集团股份有限公司 | 一种gpr52激动剂及其在医药上的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005037797A1 (en) * | 2003-10-21 | 2005-04-28 | Pharmacia Corporation | Substituted pyrazole urea compounds for the treatment of inflammation |
| WO2009107391A1 (ja) | 2008-02-27 | 2009-09-03 | 武田薬品工業株式会社 | ６員芳香環含有化合物 |
| WO2011078360A1 (ja) | 2009-12-24 | 2011-06-30 | 武田薬品工業株式会社 | アミド化合物 |
| EP2530078A1 (en) | 2010-01-27 | 2012-12-05 | Takeda Pharmaceutical Company Limited | Thiazole derivative |
| KR20180004193A (ko) * | 2015-04-29 | 2018-01-10 | 아레나 파마슈티칼스, 인크. | Gpr52와 관련된 장애의 치료 또는 예방을 위한 gpr52 조절제로서 1-헤테로아릴-인돌린-4-카르복스아미드 |
| JP7394747B2 (ja) * | 2017-09-13 | 2023-12-08 | ノバルティス アーゲー | ジフェニル誘導体及びその使用 |
-
2020
- 2020-03-13 GB GBGB2003668.7A patent/GB202003668D0/en not_active Ceased
-
2021
- 2021-03-15 HR HRP20241375TT patent/HRP20241375T1/hr unknown
- 2021-03-15 ES ES21713103T patent/ES2992600T3/es active Active
- 2021-03-15 EP EP21713103.6A patent/EP4117784B1/en active Active
- 2021-03-15 SI SI202130212T patent/SI4117784T1/sl unknown
- 2021-03-15 US US17/909,792 patent/US20240254101A1/en active Pending
- 2021-03-15 RS RS20241089A patent/RS66063B1/sr unknown
- 2021-03-15 AU AU2021235257A patent/AU2021235257A1/en active Pending
- 2021-03-15 IL IL296413A patent/IL296413B2/en unknown
- 2021-03-15 WO PCT/GB2021/050638 patent/WO2021181122A1/en not_active Ceased
- 2021-03-15 LT LTEPPCT/GB2021/050638T patent/LT4117784T/lt unknown
- 2021-03-15 DK DK21713103.6T patent/DK4117784T3/da active
- 2021-03-15 PT PT217131036T patent/PT4117784T/pt unknown
- 2021-03-15 CA CA3175429A patent/CA3175429A1/en active Pending
- 2021-03-15 SM SM20240402T patent/SMT202400402T1/it unknown
- 2021-03-15 MX MX2022011333A patent/MX2022011333A/es unknown
- 2021-03-15 PL PL21713103.6T patent/PL4117784T3/pl unknown
- 2021-03-15 KR KR1020227035100A patent/KR20220152296A/ko active Pending
- 2021-03-15 HU HUE21713103A patent/HUE068758T2/hu unknown
- 2021-03-15 BR BR112022018287A patent/BR112022018287A2/pt unknown
- 2021-03-15 FI FIEP21713103.6T patent/FI4117784T3/fi active
- 2021-03-15 CN CN202180033813.9A patent/CN115515681B/zh active Active
- 2021-03-15 JP JP2022555137A patent/JP7492597B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7492597B2 (ja) | 2024-05-29 |
| EP4117784A1 (en) | 2023-01-18 |
| SMT202400402T1 (it) | 2024-11-15 |
| GB202003668D0 (en) | 2020-04-29 |
| IL296413A (en) | 2022-11-01 |
| ES2992600T3 (en) | 2024-12-16 |
| CA3175429A1 (en) | 2021-09-16 |
| AU2021235257A1 (en) | 2022-10-06 |
| SI4117784T1 (sl) | 2025-03-31 |
| LT4117784T (lt) | 2024-10-25 |
| EP4117784B1 (en) | 2024-08-28 |
| DK4117784T3 (da) | 2024-10-14 |
| CN115515681A (zh) | 2022-12-23 |
| CN115515681B (zh) | 2024-09-03 |
| JP2023519666A (ja) | 2023-05-12 |
| RS66063B1 (sr) | 2024-11-29 |
| IL296413B1 (en) | 2025-11-01 |
| FI4117784T3 (fi) | 2024-10-10 |
| US20240254101A1 (en) | 2024-08-01 |
| KR20220152296A (ko) | 2022-11-15 |
| MX2022011333A (es) | 2022-12-08 |
| HUE068758T2 (hu) | 2025-01-28 |
| HRP20241375T1 (hr) | 2024-12-20 |
| PL4117784T3 (pl) | 2025-01-13 |
| WO2021181122A1 (en) | 2021-09-16 |
| PT4117784T (pt) | 2024-10-07 |
| IL296413B2 (en) | 2026-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022018287A2 (pt) | Compostos moduladores de gpr52 | |
| BR112022016072A2 (pt) | Compostos moduladores de gcn2, sal farmaceuticamente aceitável, seus usos, e composição farmacêutica | |
| BR112021016109A2 (pt) | Derivados de protoporfirina ix e uso dos mesmos para melhorar a saúde das plantas | |
| BR112021022758A2 (pt) | Compostos de 1-oxo-isoindolina-5-carboxamida substituídos, suas composições e métodos de tratamento com os mesmos | |
| BR112022021962A2 (pt) | Imidazopiridazinas como moduladores de il-17 | |
| BR112021019858A2 (pt) | Agentes de modulação reguladores de condutância transmembrana de fibrose cística | |
| BR112023025358A2 (pt) | Inibidores de protease como antivirais | |
| BR112021017604A2 (pt) | Compostos úteis na terapia para hiv | |
| BR112012022125A2 (pt) | composto, sal de dicloridrato, composição farmacêutica, uso do composto, e, método para tratar um paciente | |
| BRPI0517423A (pt) | composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto | |
| CO2021015264A2 (es) | Inhibidores de dihidroorotato deshidrogenasa | |
| BR112023002951A2 (pt) | Compostos de fosfolipídio e usos destes | |
| BR112017022743A2 (pt) | ?composto, composição herbicida, mistura de herbicidas e método para controlar o crescimento de vegetação indesejada? | |
| BRPI0713132B8 (pt) | compostos derivados de cinamoil-piperazina, método de preparação dos referidos compostos, composições farmacêuticas, seus usos como antagonistas de par-i e produtos | |
| MX2022005111A (es) | Compuestos moduladores del receptor 52 acoplado a proteina g (gpr52). | |
| BR112022003982A2 (pt) | Compostos heterocíclicos | |
| BR112018008423A2 (pt) | antagonistas do receptor cgrp | |
| MX2021004280A (es) | Derivados de pirazol como compuestos antagonistas de receptor de histamina h4. | |
| BR112022001390A2 (pt) | Inibidores de enzima | |
| BR112023003696A2 (pt) | Compostos moduladores de gpr52 | |
| BR112021026899A2 (pt) | Compostos heterocíclicos | |
| CL2024000742A1 (es) | Compuestos moduladores de gpr52 | |
| BRPI0408205A (pt) | derivado de anilina substituìdo, composição farmacêutica, e, uso de uma composição farmacêutica | |
| BR0315114A (pt) | Compostos, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar (alfa) e/ou ppar (gama)z e/ou utilização dos mesmos | |
| BRPI0417609B8 (pt) | derivados de 3-ciano-quinolina com atividade antiproliferativa, seu processo de preparação e uso e composição farmacêutica que os compreende |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: NXERA PHARMA UK LIMITED (GB) |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |